Menu

RedHill Biopharma Ltd.

Complementary equity research reports on RedHill Biopharma Ltd.

Report Type

Publish Date

Link

Initiation of Coverage 12 July 2017 pdf-icon_32x32.png
Initiation of Coverage - Hebrew Appendix 12 July 2017 pdf-icon_32x32.png
Q2 2017 Report 9 August 2017 pdf-icon_32x32.png
Q2 2017 - Hebrew Appendix 9 August 2017 pdf-icon_32x32.png
Immediate Report 16 October 2017 pdf-icon_32x32.png
Immediate Report - Hebrew Appendix 16 October 2017 pdf-icon_32x32.png
Q3 2017 Report 28 November 2017 pdf-icon_32x32.png
Q3 2017 Report - Hebrew Appendix 28 November 2017 pdf-icon_32x32.png
Immediate Report 13 December 2017 pdf-icon_32x32.png
Immediate Report - Hebrew Appendix 13 December 2017 pdf-icon_32x32.png
Q4 2017 Report 13 March 2018 pdf-icon_32x32.png
Q4 2017 Report - Hebrew Appendix 13 March 2018 pdf-icon_32x32.png
Q1 2018 Report 22 May 2018 pdf-icon_32x32.png
Q1 2018 Report - Hebrew Appendix 22 May 2018 pdf-icon_32x32.png
Immediate Report 31 July 2018 pdf-icon_32x32.png
Immediate Report - Hebrew Appendix 31 July 2018 pdf-icon_32x32.png
Q2 2018 Report 5 September 2018 pdf-icon_32x32.png
Q2 2018 Report - Hebrew Appendix 5 September 2018 pdf-icon_32x32.png
Q3 2018 Report 20 November 2018 pdf-icon_32x32.png
Q3 2018 Report - Hebrew Appendix 20 November 2018 pdf-icon_32x32.png